Another verdict has come down against Johnson & Johnson and their talc products. This case, like the others before it, will be appealed, but an important takeaway is that the tide appears to be shifting in favor of consumers who argue they were harmed by products that contain chemicals of concern. More specifically, juries are upholding the International Agency for Research on Cancer (IARC) decade-long classification of talc as a possible carcinogen and determining that manufacturer Johnson & Johnson is responsible for not putting labels on their Baby Powder and Shower to Shower talc products warning women of the potential link between talc and ovarian cancer.
Johnson & Johnson was ordered by a St. Louis jury to pay more than $110 million to a Virginia woman who blamed her ovarian cancer on the company’s talcum products…The company will appeal the verdict…
The lawsuit is among more than 1,000 filed in St. Louis by women across the U.S…There are more than 3,000 lawsuits accusing the world’s largest health-care company of ignoring studies linking its baby powder and Shower to Shower talc products to ovarian cancer and failing to warn customers about the risk…
Juror Lindsay Polley said that science was increasingly pointing toward talc being a cancer risk factor:
“The J&J documents acknowledge that. If we could, we would make them put on a warning label.”